Vortex Biosciences, liquid biopsy for cancer diagnosis, announces experienced start-up leader Dr. Adrian Kinkaid as new CEO
London, UK 2nd June 2021 (PR WEB) EMV Capital portfolio company, Vortex Biosciences, the cancer diagnosis biotechnology business, has announced the appointment of Dr Adrian Kinkaid as its new Chief Executive Officer. Vortex Biosciences has developed the VTX-1, a best-in-class instrument that isolates and purifies Circulating Tumor Cells (CTCs) from blood. These cells can then […]